Effect of Nesiritide in Patients with Acute Decompensated Heart Failure | Zendy

Cathal O’Connor | Zendy; Randall C. Starling | Zendy; Adrian F. Hernandez | Zendy; Paul W. Armstrong | Zendy; Kenneth Dickstein | Zendy; Vic Hasselblad | Zendy; Gretchen Heizer | Zendy; Michel Komajda | Zendy; Barry M. Massie | Zendy; John J.V. McMurray | Zendy; Markku S. Nieminen | Zendy; Craig J. Reist | Zendy; Jean-Lucien Rouleau | Zendy; Karl Swedberg | Zendy; Kirkwood F. Adams | Zendy; Stefan D. Anker | Zendy; Dan Atar | Zendy; A Battler | Zendy; Rodrigo Botero | Zendy; N. R. Bohidar | Zendy; Javed Butler | Zendy; Nadine Clausell | Zendy; Ramón Corbalán | Zendy; Maria Rosa Costanzo | Zendy; Ulf Dahlström | Zendy; Lawrence I. Deckelbaum | Zendy; Rafael Díaz | Zendy; Mark E. Dunlap | Zendy; Justin A. Ezekowitz | Zendy; DO Bruce Feldman | Zendy; G. Michael Felker | Zendy; Gregg C. Fonarow | Zendy; Daniel Gennevois | Zendy; Stephen S. Gottlieb | Zendy; James A. Hill | Zendy; Judd E. Hollander | Zendy; Jonathan G. Howlett | Zendy; Michael Hudson | Zendy; Robb D. Kociol | Zendy; Henry Krum | Zendy; Aleksandras Laucevičius | Zendy; Wayne C. Levy | Zendy; Gustavo Méndez | Zendy; Marco Metra | Zendy; Sanjay Mittal | Zendy; ByungHee Oh | Zendy; Naveen L. Pereira | Zendy; Piotr Ponikowski | Zendy; W.H. Wilson Tang | Zendy; Supachai Tanomsup | Zendy; John R. Teerlink | Zendy; F. Triposkiadis | Zendy; Richard W. Troughton | Zendy; Adriaan A. Voors | Zendy; David J. Whellan | Zendy; Faı̈ez Zannad | Zendy; Robert M. Califf | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Effect of Nesiritide in Patients with Acute Decompensated Heart Failure

Author(s) -

Cathal O’Connor,

Randall C. Starling,

Adrian F. Hernandez,

Paul W. Armstrong,

Kenneth Dickstein,

Vic Hasselblad,

Gretchen Heizer,

Michel Komajda,

Barry M. Massie,

John J.V. McMurray,

Markku S. Nieminen,

Craig J. Reist,

Jean-Lucien Rouleau,

Karl Swedberg,

Kirkwood F. Adams,

Stefan D. Anker,

Dan Atar,

A Battler,

Rodrigo Botero,

N. R. Bohidar,

Javed Butler,

Nadine Clausell,

Ramón Corbalán,

Maria Rosa Costanzo,

Ulf Dahlström,

Lawrence I. Deckelbaum,

Rafael Díaz,

Mark E. Dunlap,

Justin A. Ezekowitz,

DO Bruce Feldman,

G. Michael Felker,

Gregg C. Fonarow,

Daniel Gennevois,

Stephen S. Gottlieb,

James A. Hill,

Judd E. Hollander,

Jonathan G. Howlett,

Michael Hudson,

Robb D. Kociol,

Henry Krum,

Aleksandras Laucevičius,

Wayne C. Levy,

Gustavo Méndez,

Marco Metra,

Sanjay Mittal,

ByungHee Oh,

Naveen L. Pereira,

Piotr Ponikowski,

W.H. Wilson Tang,

Supachai Tanomsup,

John R. Teerlink,

F. Triposkiadis,

Richard W. Troughton,

Adriaan A. Voors,

David J. Whellan,

Faı̈ez Zannad,

Robert M. Califf

Publication year - 2011

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1100171

Subject(s) - nesiritide , medicine , heart failure , placebo , cardiology , confidence interval , acute decompensated heart failure , renal function , clinical endpoint , randomized controlled trial , natriuretic peptide , alternative medicine , pathology

Nesiritide is approved in the United States for early relief of dyspnea in patients with acute heart failure. Previous meta-analyses have raised questions regarding renal toxicity and the mortality associated with this agent.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research